Australian Deprescribing Network

Promoting research, awareness, practice and policy on deprescribing to improve the safe and appropriate use of medicines for all Australians.

Innovative service models to support deprescribing in hospital

Sedative and anticholinergic drugs are commonly associated with harm in older adults. The Drug Burden Index (DBI) developed by Professor Sarah Hilmer, is a validated clinical risk assessment tool which measures exposure to anticholinergics and sedatives. A bundle of resources, including the DBI in the electronic Medical Records (eMR) have been implemented in Northern Sydney Local Health District (NSLHD) and Central Coast Local Health District (CCLHD) hospitals in NSW, to help clinicians identify and prioritise high-risk older patients for medication review and facilitate deprescribing of DBI-contributing drugs where appropriate.

Click here to read more!


Researchers across Australia and internationally are working on projects to inform deprescribing in practice.


Click through to find out about our upcoming events.

Contact Us

Click here for detail on how to contact us, including media contacts. You can also subscribe to our newsletter.

Latest research

Theoretical Underpinnings of a Model to Reduce Polypharmacy and Its Negative Health Effects: Introducing the Team Approach to Polypharmacy Evaluation and Reduction (TAPER)

🎄 Join us for the @DeprescribeAU end of year journal club!
📖 Mai Duong will be leading the discussion of a recently published #deprescribing article! @shin_liau @KateNWang
⏰ Register now at

Come join us on Dec 1st for the @DeprescribeAU Journal Club discussion of a recently published #deprescribing article led by Mai Duong! @shin_liau @KateNWang

Register here:

Load More

About the Australian Deprescribing Network

Who is ADeN and why do we exist?

The Australian Deprescribing Network (ADeN) comprises of clinicians, academic researchers, policy makers, students and consumers working together to develop the evidence-base, clinical guidance and knowledge translation to facilitate deprescribing of medicines that are no longer providing benefit or are causing harm.

ADeN aims to promote research, awareness, practice and policy for the safe and appropriate use of medicines for all Australians.

This website aims to share and exchange information about deprescribing approaches and deprescribing research with the public, health care providers and researchers.                    


What is Deprescribing?

Deprescribing is the planned and supervised process of dose reduction or stopping of medication that might be causing harm, or no longer be of benefit.

Deprescribing is part of good prescribing – backing off when doses are too high, or stopping medications that are no longer needed.

To become an ADeN member, sign up to our email list and hear about upcoming opportunities, news, events and more!

Contact us

For general enquiries fill out our online contact form. Copyright 2021. Read our disclaimer.